These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 31578291)

  • 1. How HIV Nef Proteins Hijack Membrane Traffic To Promote Infection.
    Buffalo CZ; Iwamoto Y; Hurley JH; Ren X
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Nef: Taking Control of Protein Trafficking.
    Pereira EA; daSilva LL
    Traffic; 2016 Sep; 17(9):976-96. PubMed ID: 27161574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Nef-mediated CD3 down-regulation in the HIV-1 lineage increases viral infectivity and spread.
    Mesner D; Hotter D; Kirchhoff F; Jolly C
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7382-7391. PubMed ID: 32179688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multilayered and versatile inhibition of cellular antiviral factors by HIV and SIV accessory proteins.
    Sauter D; Kirchhoff F
    Cytokine Growth Factor Rev; 2018 Apr; 40():3-12. PubMed ID: 29526437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Nef Antagonizes SERINC5 Restriction by Downregulation of SERINC5 via the Endosome/Lysosome System.
    Shi J; Xiong R; Zhou T; Su P; Zhang X; Qiu X; Li H; Li S; Yu C; Wang B; Ding C; Smithgall TE; Zheng YH
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of AP-2-Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.
    Schouest B; Weiler AM; Janaka SK; Myers TA; Das A; Wilder SC; Furlott J; Baddoo M; Flemington EK; Rakasz EG; Evans DT; Friedrich TC; Maness NJ
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on HIV-1 Nef: SERINC3 and SERINC5 Identified as Restriction Factors Antagonized by the Pathogenesis Factor.
    Fackler OT
    Viruses; 2015 Dec; 7(12):6730-8. PubMed ID: 26703715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence.
    Sugden SM; Bego MG; Pham TN; Cohen ÉA
    Viruses; 2016 Mar; 8(3):67. PubMed ID: 26950141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.
    Vassena L; Giuliani E; Koppensteiner H; Bolduan S; Schindler M; Doria M
    J Virol; 2015 May; 89(10):5687-700. PubMed ID: 25822027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The autophagy protein ATG9A promotes HIV-1 infectivity.
    Mailler E; Waheed AA; Park SY; Gershlick DC; Freed EO; Bonifacino JS
    Retrovirology; 2019 Jul; 16(1):18. PubMed ID: 31269971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.
    Shelton MN; Huang MB; Ali SA; Powell MD; Bond VC
    J Virol; 2012 Jan; 86(1):406-19. PubMed ID: 22013042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HIV-1 accessory proteins Nef and Vpu downregulate total and cell surface CD28 in CD4
    Pawlak EN; Dirk BS; Jacob RA; Johnson AL; Dikeakos JD
    Retrovirology; 2018 Jan; 15(1):6. PubMed ID: 29329537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling.
    Stolp B; Abraham L; Rudolph JM; Fackler OT
    J Virol; 2010 Apr; 84(8):3935-48. PubMed ID: 20147394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Nef: a master manipulator of the membrane trafficking machinery mediating immune evasion.
    Pawlak EN; Dikeakos JD
    Biochim Biophys Acta; 2015 Apr; 1850(4):733-41. PubMed ID: 25585010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of CD4 downregulation by HIV-1 Nef.
    Kwon Y; Kaake RM; Echeverria I; Suarez M; Karimian Shamsabadi M; Stoneham C; Ramirez PW; Kress J; Singh R; Sali A; Krogan N; Guatelli J; Jia X
    Nat Struct Mol Biol; 2020 Sep; 27(9):822-828. PubMed ID: 32719457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIM-mediated inhibition of HIV-1 release is antagonized by Nef but potentiated by SERINC proteins.
    Li M; Waheed AA; Yu J; Zeng C; Chen HY; Zheng YM; Feizpour A; Reinhard BM; Gummuluru S; Lin S; Freed EO; Liu SL
    Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5705-5714. PubMed ID: 30842281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological relevance of ACOT8-Nef interaction in HIV infection.
    Palmeira JDF; Argañaraz GA; de Oliveira GXLM; Argañaraz ER
    Rev Med Virol; 2019 Sep; 29(5):e2057. PubMed ID: 31179598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a highly conserved valine-glycine-phenylalanine amino acid triplet required for HIV-1 Nef function.
    Meuwissen PJ; Stolp B; Iannucci V; Vermeire J; Naessens E; Saksela K; Geyer M; Vanham G; Arien KK; Fackler OT; Verhasselt B
    Retrovirology; 2012 Apr; 9():34. PubMed ID: 22537596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild.
    Heigele A; Kmiec D; Regensburger K; Langer S; Peiffer L; Stürzel CM; Sauter D; Peeters M; Pizzato M; Learn GH; Hahn BH; Kirchhoff F
    Cell Host Microbe; 2016 Sep; 20(3):381-391. PubMed ID: 27631701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals.
    Mwimanzi F; Toyoda M; Mahiti M; Mann JK; Martin JN; Bangsberg D; Brockman MA; Goulder P; Kirchhoff F; Brumme ZL; Ndung'u T; Ueno T
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.